University of Oxford

Cancer Epidemiology Unit

You are here: HomeResearch

The Endogenous Hormones and Prostate Cancer Collaborative Group

The Endogenous Hormones and Prostate Cancer Collaborative Group conducts pooled analyses of the relationship between endogenous sex hormones, insulin-like growth factors and subsequent prostate cancer risk and includes collaborations with scientists from 21 studies world-wide.

The Endogenous Hormones and Prostate Cancer Collaborative Group conducts pooled analyses of endogenous (natural) hormones in relation to prostate cancer risk. The group was established in 2004 with its secretariat in the Cancer Epidemiology Unit, and had its first meeting in July 2005. Scientists from around 20 world-wide studies are collaborating in this work, and the group is looking at the roles of oestrogens, androgens and growth factors in the aetiology of prostate cancer. The project has collected data from around 6000 men with prostate cancer and around 5000 control men without the disease. First results were published in 2008 and showed an association between risk of prostate cancer and levels of the growth hormone IGF-1 (insulin-like growth factor 1).

View publications for the Endogenous Hormones and Prostate Cancer Collaborative Group.


Up